Search Results - "биологическая активность"

Source: Chemistry; Том 17, № 2 (2025): Вестник Южно-Уральского государственного университета. Серия: Химия; 116–168 ; Химия; Том 17, № 2 (2025): Вестник Южно-Уральского государственного университета. Серия: Химия; 116–168 ; 2412-0413 ; 2076-0493

Subject Terms: condensation reactions, thiosemicarbazones, 1,2,4-triazine-3-thione and its derivatives, complexation, S-alkylation, annulation, cyclization, practical application, biological activity, реакции конденсации, тиосемикарбазоны, 1,2,4-триазин-3-тион и его производные, комплексообразование, S-алкилирование, аннелирование, циклизация, практическое применение, биологическая активность

File Description: application/pdf

Relation: https://vestnik.susu.ru/chemistry/article/view/15152/11170; https://vestnik.susu.ru/chemistry/article/view/15152

Availability: https://vestnik.susu.ru/chemistry/article/view/15152

View record from BASE

18

Academic Journal

Expert Assessment of In Vitro Potency Assays for Monoclonal Antibody Preparations ; Экспертная оценка определения специфической активности препаратов моноклональных антител биологическим методом in vitro

Authors: N. A. Alpatova, O. V. Golovinskaya, M. L. Baykova, S. L. Lysikova, L. A. Gaiderova, Н. А. Алпатова, О. В. Головинская, М. Л. Байкова, С. Л. Лысикова, Л. А. Гайдерова

Contributors: This study was conducted by the Scientific Centre for Expert Evaluation of Medicinal Products as part of the applied research funded under State Assignment No. 056-00001-25-00 (R&D Registry No. 124022200103-5)., Работа выполнена в рамках государственного задания ФГБУ «НЦЭСМП» Минздрава России № 056-00001-25-00 на проведение прикладных научных исследований (номер государственного учета НИР 124022200103-5).

Source: Regulatory Research and Medicine Evaluation; Том 15, № 1 (2025); 44-56 ; Регуляторные исследования и экспертиза лекарственных средств; Том 15, № 1 (2025); 44-56 ; 3034-3453 ; 3034-3062 ; 10.30895/1991-2919-2025-15-1

Subject Terms: культуры клеток, medicinal products, quality assessment of medicinal products, in vitro bioassay, regulatory standards, biological activity, potency, cell cultures, лекарственные препараты, оценка качества лекарственных препаратов, биологические методики in vitro, нормативная документация, биологическая активность, специфическая активность

File Description: application/pdf

Relation: https://www.vedomostincesmp.ru/jour/article/view/733/1801; https://www.vedomostincesmp.ru/jour/article/downloadSuppFile/733/823; https://www.vedomostincesmp.ru/jour/article/downloadSuppFile/733/825; https://www.vedomostincesmp.ru/jour/article/downloadSuppFile/733/831; Халимова АА, Орлов АС, Таубэ АА. Анализ локализации производства биотехнологических лекарственных препаратов в России с учетом происхождения активных фармацевтических субстанций. Ведомости Научного центра экспертизы средств медицинского применения. Регуляторные исследования и экспертиза лекарственных средств. 2024;14(1):53–61. https://doi.org/10.30895/1991-2919-2024-14-1-53-61; Gogesch P, Dudek S, van Zandbergen G, Waibler Z, Anzaghe M. The role of Fc receptors on the effectiveness of therapeutic monoclonal antibodies. Int J Mol Sci. 2021;22(16):8947. https://doi.org/10.3390/ijms22168947; Wang X, An Z, Luo W, Xia N, Zhao Q. Molecular and functional analysis of monoclonal antibodies in support of biologics development. Protein Cell. 2018;9(1):74–85. https://doi.org/10.1007/s13238-017-0447-x; Alt N, Zhang TY, Motchnik P, Taticek R, Quarmby V, Schlothauer T, et al. Determination of critical quality attributes for monoclonal antibodies using quality by design principles. Biologicals. 2016;44(5):291–305. https://doi.org/10.1016/j.biologicals.2016.06.005; Gao X, Wang W, Tesar D, Wei B, Eschelbach J, Kelley RF, Jiang G. An approach to bioactivity assessment for critical quality attribute identification based on antibody-antigen complex structure. J Pharm Sci. 2021;110(4):1652–60. https://doi.org/10.1016/j.xphs.2020.12.027; Joshi S, Rathore AS, Krull IS. Analytical characterization of biotherapeutic products, Part II: The analytical toolbox. LCGC North Am. 2018;36(11):814–22.; Rathore AS, Dash R. Tools for functional assessment of biotherapeutics. LCGC North Am. 2021;39(6):272–77.; Cedeño-Arias M, Sánchez-Ramírez J, Blanco-Santana R, Rengifo-Calzado E. Validation of a flow cytometry based binding assay for evaluation of monoclonal antibody recognizing EGF receptor. Sci Pharm. 2011;79(3):569–81. https://doi.org/10.3797/scipharm.1104-18; Kamen L, Myneni S, Langsdorf C, Kho E, Ordonia B, Thakurta T, et al. A novel method for determining antibody-dependent cellular phagocytosis. J Immunol Methods. 2019;468:55–60. https://doi.org/10.1016/j.jim.2019.03.001; Dash R, Singh SK, Chirmule N, Rathore AS. Assessment of functional characterization and comparability of biotherapeutics: a review. AAPS J. 2021;24(1):15. https://doi.org/10.1208/s12248-021-00671-0; Heinrich L, Tissot N, Hartmann DJ, Cohen R. Comparison of the results obtained by ELISA and surface plasmon resonance for the determination of antibody affinity. J Immunol Methods. 2010;352(1–2):13–22. https://doi.org/10.1016/j.jim.2009.10.002; Register AC, Tarighat SS, Lee HY. Bioassay development for bispecific antibodies-challenges and opportunities. Int J Mol Sci. 2021;22(10):5350. https://doi.org/10.3390/ijms22105350; Wang L, Yu C, Wang J. Development of reporter gene assays to determine the bioactivity of biopharmaceuticals. Biotechnol Adv. 2020;39:107466. https://doi.org/10.1016/j.biotechadv.2019.107466; Chen W, Pandey M, Sun H, Rolong A, Cao M, Liu D, et al. Development of a mechanism of action-reflective, dual target cell-based reporter bioassay for a bispecific monoclonal antibody targeting human CTLA-4 and PD-1. MAbs. 2021;13(1):1914359. https://doi.org/10.1080/19420862.2021.1914359; Lallemand С, Liang F, Staub F, Simansour M, Vallette B, Huang L, et al. A novel system for the quantification of the ADCC activity of therapeutic antibodies. J Immunol Res. 2017;2017:1–19. https://doi.org/10.1155/2017/3908289; Wang L, Yu C, Yang Y, Gao K, Wang J. Development of a robust reporter gene assay to measure the bioactivity of anti-PD-1/anti-PD-L1 therapeutic antibodies. J Pharm Biomed Anal. 2017;145:447–53 https://doi.org/10.1016/j.jpba.2017.05.011; Alhazmi HA, Albratty M. Analytical techniques for the characterization and quantification of monoclonal antibodies. Pharmaceuticals (Basel). 2023;16(2):291. https://doi.org/10.3390/ph16020291; Bansal R, Dash R, Rathore AS. Impact of mAb aggregation on its biological activity: Rituximab as a case study. J Pharm Sci. 2020;109(9):2684–98. https://doi.org/10.1016/j.xphs.2020.05.015; Tada M, Ishii-Watabe A, Suzuki T, Kawasaki N. Development of a cell-based assay measuring the activation of FcγRIIa for the characterization of therapeutic monoclonal antibodies. PLoS One. 2014;9(4):e95787. https://doi.org/10.1371/journal.pone.0095787; Geigert J. Quality attributes of a biopharmaceutical. In: Geigert J. The challenge of CMC regulatory compliance for biopharmaceuticals. Switzerland: Springer; 2019. P. 311–29.; Алпатова НА, Гайдерова ЛА, Яковлев АК, Мотузова ЕВ, Лысикова СЛ, Солдатов АА, Авдеева ЖИ. Особенности определения специфической активности биотехнологических лекарственных средств. Биопрепараты. Профилактика, диагностика, лечение. 2017;17(1):13–26. EDN: YHSSGL; Prior S, Hufton SE, Fox B, Dougall T, Rigsby P, Bristow A. International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab. MAbs. 2018;10(1):129–42. https://doi.org/10.1080/19420862.2017.1386824; Rižner TL, Adamski J. It is high time to discontinue use of misidentified and contaminated cells: Guidelines for description and authentication of cell lines. J Steroid Biochem Mol Biol. 2018;182:1–3. https://doi.org/10.1016/j.jsbmb.2017.12.017; Мельникова ЕВ, Меркулова ОВ, Меркулов ВА, Олефир ЮВ, Ручко СВ, Бокованов ВЕ. Идентификация клеточных линий человека с использованием метода генотипирования короткими тандемными повторами: мировая практика. Биофармацевтический журнал. 2015;7(6):3–10. EDN: VRRBXF; Хорольский МД, Семенова ИС, Мельникова ЕВ, Олефир ЮВ. Применение метода коротких тандемных повторов для аутентификации клеточных линий. БИОпрепараты. Профилактика, диагностика, лечение. 2019;19(4):251–60. https://doi.org/10.30895/2221-996X-2019-19-4-251-260; White JR, Abodeely M, Ahmed S, Debauve G, Johnson E, Meyer DM, et al. Best practices in bioassay development to support registration of biopharmaceuticals. Biotechniques. 2019;67(3):126–37. https://doi.org/10.2144/btn-2019-0031; Zimmermann H, Gerhard D, Dingermann T, Hothorn LA. Statistical aspects of design and validation of microtitre-plate-based linear and non-linear parallel in vitro bioassays. Biotechnol J. 2010;5(1):62–74. https://doi.org/10.1002/biot.200900146; Surowka M, Klein C. A pivotal decade for bispecific antibodies? MAbs. 2024;16(1):2321635. https://doi.org/10.1080/19420862.2024.2321635; Nie S, Wang Z, Moscoso-Castro M, D’Souza P, Lei C, Xu J, Gu J. Biology drives the discovery of bispecific antibodies as innovative therapeutics. Antib Ther. 2020;3(1):18–62. https://doi.org/10.1093/abt/tbaa003; Mohan N, Ayinde S, Peng H, Dutta S, Shen Y, Falkowski VM. Structural and functional characterization of IgG- and non-IgG-based T-cell-engaging bispecific antibodies. Front Immunol. 2024;15:1376096. https://doi.org/10.3389/fimmu.2024.1376096; Lee HY, Contreras E, Register AC, Wu Q, Abadie K, Garcia K, et al. Development of a bioassay to detect T-cell-activating impurities for T-cell-dependent bispecific antibodies. Sci Rep. 2019;9(1):3900. https://doi.org/10.1038/s41598-019-40689-1; Lee HY, Schaefer G, Lesaca I, Lee CV, Wong PY, Jiang G. “Two-in-One” approach for bioassay selection for dual specificity antibodies. J Immunol Methods. 2017;448:74–9. https://doi.org/10.1016/j.jim.2017.05.011; Головинская ОВ, Лысикова СЛ, Лебедева ЮН, Алпатова НА, Мовсесянц АА, Меркулов ВА. Рекомендации по изложению методики оценки биологической (специфической) активности биотехнологических лекарственных препаратов в нормативной документации. БИОпрепараты. Профилактика, диагностика, лечение. 2018;18(3):168–74. https://doi.org/10.30895/2221-996X-2018-18-3-168-174; https://www.vedomostincesmp.ru/jour/article/view/733